Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (141-150 of 399) with videos related to

Pageof 40
Sort By:
Kidney International. Supplement|October 16, 2004
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetesJosephine M Forbes, Merlin C Thomas, Suzanne R Thorpe, et al.
The Medical Journal of Australia|August 9, 2006
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)Merlin C Thomas, Andrew J Weekes, Olivia J Broadley, et al.
Kidney International|July 9, 2003
Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetesJie Qin, Zhili Zhang, Jie Liu, et al.
American Journal of Nephrology|June 17, 2010
Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathyVicki Thallas-Bonke, Melinda T Coughlan, Leon A Bach, et al.
Antioxidants & Redox Signaling|February 25, 2016
Diabetes and Kidney Disease: Role of Oxidative StressJay C Jha, Claudine Banal, Bryna S M Chow, et al.
The American Journal of Pathology|August 26, 2003
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietinStella Sarlos, Bishoy Rizkalla, Christina J Moravski, et al.
Clinical and Experimental Nephrology|September 30, 2006
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL studyKiyoshi Kurokawa, Juliana C N Chan, Mark E Cooper, et al.
Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2002
Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 ratsSally A Mifsud, Sandford L Skinner, Mark E Cooper, et al.
Kidney International|August 26, 2004
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard MacIsaac, et al.
Pageof 40

Showing results (141-150 of 399) with videos related to

Sort By:
Pageof 40
Kidney International. Supplement|October 16, 2004
The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetesJosephine M Forbes, Merlin C Thomas, Suzanne R Thorpe, et al.
The Medical Journal of Australia|August 9, 2006
The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)Merlin C Thomas, Andrew J Weekes, Olivia J Broadley, et al.
Kidney International|July 9, 2003
Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetesJie Qin, Zhili Zhang, Jie Liu, et al.
American Journal of Nephrology|June 17, 2010
Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathyVicki Thallas-Bonke, Melinda T Coughlan, Leon A Bach, et al.
Antioxidants & Redox Signaling|February 25, 2016
Diabetes and Kidney Disease: Role of Oxidative StressJay C Jha, Claudine Banal, Bryna S M Chow, et al.
The American Journal of Pathology|August 26, 2003
Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietinStella Sarlos, Bishoy Rizkalla, Christina J Moravski, et al.
Clinical and Experimental Nephrology|September 30, 2006
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL studyKiyoshi Kurokawa, Juliana C N Chan, Mark E Cooper, et al.
Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2002
Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 ratsSally A Mifsud, Sandford L Skinner, Mark E Cooper, et al.
Kidney International|August 26, 2004
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard MacIsaac, et al.
Pageof 40